Biomedical Sciences and CoBRE Host-Pathogen group present Richard K. Plemper Aug. 29
On Wednesday, August 29 the Host-Pathogen CoBRE team and the SMHS Department of Biomedical Sciences will host a presentation by Richard K. Plemper, PhD, entitled “Developing Novel Therapeutics against Influenza Viruses and Respiratory Viruses Associated with Influenza-Like Disease.”
A professor at Georgia State University’s Institute for Biomedical Sciences, Dr. Plemper is an experienced molecular virologist and biochemist by training who has assembled a strong research team that brings together collaborators with diverse areas of expertise including molecular virologists, synthetic and medicinal chemists, and pharmacologists to meet the drug development goals of its studies. He has established a productive antivirals discovery and development research program (with particular focus on pathogens of the myxo– and pneumovirus families) that has advanced the fundamental understanding of paramyxo– and pneumovirus entry and replication, and the development of novel antiviral candidates.
After 12 years at Emory University, in 2013 he joined the newly established Institute for Biomedical Sciences at Georgia State University with his research team. Enjoying tangible institutional support to advance infrastructure and equipment of his laboratory, he built a state-of-the-art automated drug-screening facility at GSU. Combined with an outstanding biochemistry infrastructure and vivarium in the building, his laboratory has full control over all mission-critical pre-clinical stages of the drug discovery and development pipeline.
The presentation is free and open to everyone. It will be held in SMHS Room E101 (the Charles H. Fee, MD, Auditorium) at noon.